Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Diseases: From Mechanistic Insights to Biomarkers

Phase I/II clinical trials of autologous hematopoietic stem cell transplantation (AHSCT) have led to increased safety and efficacy of this therapy for severe and refractory autoimmune diseases (AD). Recent phase III randomized studies have demonstrated that AHSCT induces long-term disease remission...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Front Immunol
Auteurs principaux: Malmegrim, Kelen Cristina Ribeiro, Lima-Júnior, João Rodrigues, Arruda, Lucas Coelho Marlière, de Azevedo, Júlia Teixeira Cottas, de Oliveira, Gislane Lelis Vilela, Oliveira, Maria Carolina
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2018
Sujets:
Immunology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6250746/
https://ncbi.nlm.nih.gov/pubmed/30505303
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.02602
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires